Covid-19

COVID-19: Proactive Action Plan

Verona, Italy (24 November 2020) – In anticipation of the second wave of COVID-19 pandemic and in order to safeguard our employees’ wellbeing as well as our clients’ interests, starting from February CROS NT  has taken and continues to apply and review the following actions as a precautionary measure in our offices around the world:…

Read more
Asthma Study

CROS NT Biostatisticians Co-Author Moderate Asthma Study Results in The Lancet Medical Journal

CROS NT’s Chairman, Paolo Morelli, and biostatistician, Marco Pannacci, are co-authors on a recent paper published in The Lancet Respiratory Medicine featuring the results of a moderate asthma clinical trial sponsored by the Italian Medicines Agency (AIFA). The full article can be found on the Lancet’s website. Paolo Morelli, given his statistical experience and background…

Read more

CROS NT SRL Announces Acquisition of Stat-Tech Services, LLC

To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat-Tech Services, LLC – a Contract Research Organization (CRO) with extensive expertise in the medical devices sector. The financial details of the transaction remain confidential. CROS NT, an international CRO specializing in biometrics services, see the acquisition as an…

Read more
DATATRAK

CROS NT Joins DATATRAK Connect™ Partner Program

CROS NT has expanded its life sciences technology portfolio by joining the DATATRAK Connect™ Program – a program which allows for extended service offerings for the drug development process with the goal of reducing study costs and furthering business development objectives. Under this partnership program, CROS NT can provide DATATRAK’s clinical trial technologies including Electronic…

Read more